Skip to main content
Top
Published in: Sports Medicine - Open 1/2016

Open Access 01-12-2016 | Original Research Article

Acute Changes in Inflammatory Biomarker Levels in Recreational Runners Participating in a Marathon or Half-Marathon

Authors: Markus Niemelä, Päivikki Kangastupa, Onni Niemelä, Risto Bloigu, Tatu Juvonen

Published in: Sports Medicine - Open | Issue 1/2016

Login to get access

Abstract

Background

Strenuous physical activity activates the participant’s immune responses; however, few studies exist, observing exercise-induced simultaneous changes in mediators of inflammation.

Methods

We examined individual responses in soluble urokinase-type plasminogen activator receptor (suPAR), a marker of immune activation, soluble endocytic receptor for haptoglobin-hemoglobin complexes (CD163), a marker of monocyte-macrophage activation, C-reactive protein (CRP), and pro- and anti-inflammatory cytokines from blood samples drawn at baseline, at 3- and 48-h post-races from recreational runners who successfully completed the marathon (199 ± 8 min, n = 4) or half-marathon (132 ± 4 min, n = 4) run. For comparisons, biomarkers reflecting muscle, heart, kidney, and liver functions were measured.

Results

Significant 3-h post-race increases occurred in levels of suPAR (p < 0.01), CD163 (p < 0.05), white blood cells (p < 0.001), pro-inflammatory cytokines, interleukin-6 (IL-6) (p < 0.001), IL-8 (p < 0.05), and anti-inflammatory cytokine IL-10 (p < 0.05), whereas tumor necrosis factor-α (TNF-α) and transforming growth factor-β (TGF-β) remained relatively stable. Full-marathon running lead to more pronounced increases in suPAR, CD163, IL-8, and IL-10 than half-marathon running. In addition, 3-h post-race increases of all these parameters correlated significantly with changes in serum TNF-α and cortisol. The 48-h levels of serum suPAR and both pro- and anti-inflammatory cytokines had decreased to baseline levels, whereas CRP, a marker of acute phase response, increased in those with the most prominent IL-6 and IL-10 elevations in their preceding samples. The highest suPAR, CRP, IL-6, TNF-α, IL-10, and cortisol levels were noted in the individual with the most severe post-race fatigue.

Conclusions

Prolonged running increases mediators of inflammation in an exercise-dose-dependent manner which should be considered in the assessment of health status of physically active individuals after recent acute bouts of strenuous exercise.
Literature
1.
go back to reference Lavie CJ, O'Keefe JH, Sallis RE. Exercise and the heart—the harm of too little and too much. Curr Sports Med Rep. 2015;14:104–9.CrossRefPubMed Lavie CJ, O'Keefe JH, Sallis RE. Exercise and the heart—the harm of too little and too much. Curr Sports Med Rep. 2015;14:104–9.CrossRefPubMed
2.
go back to reference O'Donovan G, Blazevich AJ, Boreham C, Cooper AR, Crank H, Ekelund U, et al. The ABC of physical activity for health: a consensus statement from the British Association of Sport and Exercise Sciences. J Sports Sci. 2010;28:573–91.CrossRefPubMed O'Donovan G, Blazevich AJ, Boreham C, Cooper AR, Crank H, Ekelund U, et al. The ABC of physical activity for health: a consensus statement from the British Association of Sport and Exercise Sciences. J Sports Sci. 2010;28:573–91.CrossRefPubMed
3.
go back to reference Ruiz JR, Morán M, Arenas J, Lucia A. Strenuous endurance exercise improves life expectancy: it's in our genes. Br J Sports Med. 2011;45:159–61.CrossRefPubMed Ruiz JR, Morán M, Arenas J, Lucia A. Strenuous endurance exercise improves life expectancy: it's in our genes. Br J Sports Med. 2011;45:159–61.CrossRefPubMed
4.
go back to reference Schnohr P, O'Keefe JH, Marott JL, Lange P, Jensen GB. Dose of jogging and long-term mortality: the Copenhagen city heart study. J Am Coll Cardiol. 2015;65:411–9.CrossRefPubMed Schnohr P, O'Keefe JH, Marott JL, Lange P, Jensen GB. Dose of jogging and long-term mortality: the Copenhagen city heart study. J Am Coll Cardiol. 2015;65:411–9.CrossRefPubMed
5.
go back to reference Fortescue EB, Shin AY, Greenes DS, Mannix RC, Agarwal S, Feldman BJ, et al. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med. 2007;49:137–43.e1.CrossRefPubMed Fortescue EB, Shin AY, Greenes DS, Mannix RC, Agarwal S, Feldman BJ, et al. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med. 2007;49:137–43.e1.CrossRefPubMed
6.
go back to reference McCullough PA, Chinnaiyan KM, Gallagher MJ, Colar JM, Geddes T, Gold JM, et al. Changes in renal markers and acute kidney injury after marathon running. Nephrology (Carlton). 2011;16:194–9.CrossRef McCullough PA, Chinnaiyan KM, Gallagher MJ, Colar JM, Geddes T, Gold JM, et al. Changes in renal markers and acute kidney injury after marathon running. Nephrology (Carlton). 2011;16:194–9.CrossRef
7.
go back to reference Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston Marathon. Circulation. 2006;114:2325–33.CrossRefPubMed Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston Marathon. Circulation. 2006;114:2325–33.CrossRefPubMed
8.
go back to reference Bernecker C, Scherr J, Schinner S, Braun S, Scherbaum WA, Halle M. Evidence for an exercise induced increase of TNF-alpha and IL-6 in marathon runners. Scand J Med Sci Sports. 2013;23:207–14.CrossRefPubMed Bernecker C, Scherr J, Schinner S, Braun S, Scherbaum WA, Halle M. Evidence for an exercise induced increase of TNF-alpha and IL-6 in marathon runners. Scand J Med Sci Sports. 2013;23:207–14.CrossRefPubMed
9.
go back to reference Muñoz-Cánoves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 2013;280:4131–48.CrossRefPubMedPubMedCentral Muñoz-Cánoves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 2013;280:4131–48.CrossRefPubMedPubMedCentral
10.
go back to reference Ostrowski K, Schjerling P, Pedersen BK. Physical activity and plasma interleukin-6 in humans—effect of intensity of exercise. Eur J Appl Physiol. 2000;83:512–5.CrossRefPubMed Ostrowski K, Schjerling P, Pedersen BK. Physical activity and plasma interleukin-6 in humans—effect of intensity of exercise. Eur J Appl Physiol. 2000;83:512–5.CrossRefPubMed
11.
go back to reference Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–65.CrossRefPubMed Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–65.CrossRefPubMed
12.
go back to reference Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014;2:288–94.CrossRefPubMed Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014;2:288–94.CrossRefPubMed
13.
go back to reference McGinnis GR, Ballmann C, Peters B, Nanayakkara G, Roberts M, Amin R, et al. Interleukin-6 mediates exercise preconditioning against myocardial ischemia reperfusion injury. Am J Physiol Heart Circ Physiol. 2015;308:H1423–33.CrossRefPubMed McGinnis GR, Ballmann C, Peters B, Nanayakkara G, Roberts M, Amin R, et al. Interleukin-6 mediates exercise preconditioning against myocardial ischemia reperfusion injury. Am J Physiol Heart Circ Physiol. 2015;308:H1423–33.CrossRefPubMed
14.
go back to reference Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy. J Med Virol. 2008;80:209–16.CrossRefPubMed Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy. J Med Virol. 2008;80:209–16.CrossRefPubMed
15.
go back to reference Koch A, Voigt S, Kruschinski C, Sanson E, Dückers H, Horn A, et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care. 2011;15:R63.CrossRefPubMedPubMedCentral Koch A, Voigt S, Kruschinski C, Sanson E, Dückers H, Horn A, et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care. 2011;15:R63.CrossRefPubMedPubMedCentral
18.
go back to reference Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, et al. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood. 2009;113:2578–86.CrossRefPubMed Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, et al. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood. 2009;113:2578–86.CrossRefPubMed
19.
go back to reference Casagranda I, Vendramin C, Callegari T, Vidali M, Calabresi A, Ferrandu G, et al. Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department. Intern Emerg Med. 2015;10:725–30.CrossRefPubMed Casagranda I, Vendramin C, Callegari T, Vidali M, Calabresi A, Ferrandu G, et al. Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department. Intern Emerg Med. 2015;10:725–30.CrossRefPubMed
20.
go back to reference Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med. 2010;268:296–308.CrossRefPubMed Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med. 2010;268:296–308.CrossRefPubMed
21.
22.
go back to reference de Couto G, Liu W, Tseliou E, Sun B, Makkar N, Kanazawa H, et al. Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest. 2015;125:3147–62.CrossRefPubMedPubMedCentral de Couto G, Liu W, Tseliou E, Sun B, Makkar N, Kanazawa H, et al. Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest. 2015;125:3147–62.CrossRefPubMedPubMedCentral
23.
go back to reference Ernandez T, Mayadas TN. Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int. 2009;76:262–76.CrossRefPubMed Ernandez T, Mayadas TN. Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int. 2009;76:262–76.CrossRefPubMed
24.
go back to reference Latvala J, Hietala J, Koivisto H, Järvi K, Anttila P, Niemelä O. Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol. 2005;100:1303–10.CrossRefPubMed Latvala J, Hietala J, Koivisto H, Järvi K, Anttila P, Niemelä O. Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol. 2005;100:1303–10.CrossRefPubMed
25.
go back to reference Vidali M, Hietala J, Occhino G, Ivaldi A, Sutti S, Niemelä O, et al. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers. Free Radic Biol Med. 2008;45:306–11.CrossRefPubMed Vidali M, Hietala J, Occhino G, Ivaldi A, Sutti S, Niemelä O, et al. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers. Free Radic Biol Med. 2008;45:306–11.CrossRefPubMed
26.
go back to reference Nieman DC. Special feature for the Olympics: effects of exercise on the immune system: exercise effects on systemic immunity. Immunol Cell Biol. 2000;78:496–501.CrossRefPubMed Nieman DC. Special feature for the Olympics: effects of exercise on the immune system: exercise effects on systemic immunity. Immunol Cell Biol. 2000;78:496–501.CrossRefPubMed
28.
go back to reference di Penta A, Moreno B, Reix S, Fernandez-Diez B, Villanueva M, Errea O, et al. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One. 2013;8:e54722.CrossRefPubMedPubMedCentral di Penta A, Moreno B, Reix S, Fernandez-Diez B, Villanueva M, Errea O, et al. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One. 2013;8:e54722.CrossRefPubMedPubMedCentral
29.
go back to reference Kurra V, Eräranta A, Jolma P, Vehmas TI, Riutta A, Moilanen E, et al. Hyperuricemia, oxidative stress, and carotid artery tone in experimental renal insufficiency. Am J Hypertens. 2009;22:964–70.CrossRefPubMed Kurra V, Eräranta A, Jolma P, Vehmas TI, Riutta A, Moilanen E, et al. Hyperuricemia, oxidative stress, and carotid artery tone in experimental renal insufficiency. Am J Hypertens. 2009;22:964–70.CrossRefPubMed
30.
go back to reference Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond). 2003;105:425–30.CrossRef Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond). 2003;105:425–30.CrossRef
31.
go back to reference Devries MC, Hamadeh MJ, Glover AW, Raha S, Samjoo IA, Tarnopolsky MA. Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic Biol Med. 2008;45:503–11.CrossRefPubMed Devries MC, Hamadeh MJ, Glover AW, Raha S, Samjoo IA, Tarnopolsky MA. Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic Biol Med. 2008;45:503–11.CrossRefPubMed
32.
go back to reference Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med. 2001;27:803–11.CrossRefPubMed Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med. 2001;27:803–11.CrossRefPubMed
34.
go back to reference Lappalainen H, Tiula E, Uotila L, Mänttäri M. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Crit Care Med. 2002;30:2212–5.CrossRefPubMed Lappalainen H, Tiula E, Uotila L, Mänttäri M. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Crit Care Med. 2002;30:2212–5.CrossRefPubMed
35.
go back to reference Lippi G, Schena F, Dipalo M, Montagnana M, Salvagno GL, Aloe R, et al. Troponin I measured with a high sensitivity immunoassay is significantly increased after a half marathon run. Scand J Clin Lab Invest. 2012;72:467–70.CrossRefPubMed Lippi G, Schena F, Dipalo M, Montagnana M, Salvagno GL, Aloe R, et al. Troponin I measured with a high sensitivity immunoassay is significantly increased after a half marathon run. Scand J Clin Lab Invest. 2012;72:467–70.CrossRefPubMed
36.
go back to reference Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem. 2009;55:101–8.CrossRefPubMed Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem. 2009;55:101–8.CrossRefPubMed
37.
go back to reference Trivax JE, Franklin BA, Goldstein JA, Chinnaiyan KM, Gallagher MJ, de Jong AT, et al. Acute cardiac effects of marathon running. J Appl Physiol (1985). 2010;108:1148–53.CrossRef Trivax JE, Franklin BA, Goldstein JA, Chinnaiyan KM, Gallagher MJ, de Jong AT, et al. Acute cardiac effects of marathon running. J Appl Physiol (1985). 2010;108:1148–53.CrossRef
38.
go back to reference Dawson EA, Whyte GP, Black MA, Jones H, Hopkins N, Oxborough D, et al. Changes in vascular and cardiac function after prolonged strenuous exercise in humans. J Appl Physiol (1985). 2008;105:1562–8.CrossRef Dawson EA, Whyte GP, Black MA, Jones H, Hopkins N, Oxborough D, et al. Changes in vascular and cardiac function after prolonged strenuous exercise in humans. J Appl Physiol (1985). 2008;105:1562–8.CrossRef
39.
go back to reference Ruskoaho H, Kinnunen P, Taskinen T, Vuolteenaho O, Leppäluoto J, Takala TE. Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium. Effects of exercise. Circulation. 1989;80:390–400.CrossRefPubMed Ruskoaho H, Kinnunen P, Taskinen T, Vuolteenaho O, Leppäluoto J, Takala TE. Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium. Effects of exercise. Circulation. 1989;80:390–400.CrossRefPubMed
Metadata
Title
Acute Changes in Inflammatory Biomarker Levels in Recreational Runners Participating in a Marathon or Half-Marathon
Authors
Markus Niemelä
Päivikki Kangastupa
Onni Niemelä
Risto Bloigu
Tatu Juvonen
Publication date
01-12-2016
Publisher
Springer International Publishing
Published in
Sports Medicine - Open / Issue 1/2016
Print ISSN: 2199-1170
Electronic ISSN: 2198-9761
DOI
https://doi.org/10.1186/s40798-016-0045-0

Other articles of this Issue 1/2016

Sports Medicine - Open 1/2016 Go to the issue